retatrutide weight loss clinical trial Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Weight Loss Results:Trial Data

There is emerging evidence of re-differentiation of -cells after weight loss which can improve insulin secretion [27,28]

Notably, the majority of mechanistic data supporting this concentration-dependent model derives from preclinical studies using mouse pancreatic -cells and clonal cell lines, with limited validation in human islet studies, necessitating further clinical investigation to confirm these concentration thresholds in human diabetes treatment [23,24,25,26]

A major challenge is that many cannabis smokers also use tobacco products [129]

Similarly, the NUPR1 inhibitor ZZW-115 triggers ferroptosis associated with mitochondrial dysfunction by downregulating GPX4 and SLC7A11 expression (142)